title: Expanding the arsenal: metformin for the treatment of triple-negative breast cancer?
authors.affiliation: MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Sao
authors.initials: S
authors.lastname: Jiralerspong
authors.forename: Ana M
authors.initials: AM
authors.lastname: Gonzalez-Angulo
authors.forename: Mien-Chie
authors.initials: MC
authors.lastname: Hung
mesh_terms: D055372:AMP-Activated Protein Kinases / Q000378:metabolism; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D017209:Apoptosis; D001943:Breast Neoplasms / Q000188:drug therapy*; D066246:ErbB Receptors / Q000378:metabolism; D005260:Female; D006801:Humans; D008687:Metformin / Q000494:pharmacology* / Q000627:therapeutic use; D015398:Signal Transduction
chemical_list: D000970:Antineoplastic Agents; D008687:Metformin; D066246:ErbB Receptors; D055372:AMP-Activated Protein Kinases